Nvidia Faces Legal Battle Over Patent Dispute in Texas Federal Court

Nvidia Corporation, known for its cutting-edge technology and substantial market influence, is currently embroiled in legal proceedings regarding alleged patent infringement. The lawsuit, filed on Tuesday in a Texas federal court, claims that Nvidia’s data centers have been utilizing technology covered by five networking patents previously held by Avaya Inc. These patents underline critical aspects…

Read More

Wisconsin Judge Invalidates Eyeglass Lens Patents, Citing Prior Art Precedent

In the ongoing legal battle over eyeglass lens patents, a Wisconsin federal judge has once again invalidated two patents, asserting that a prior patent disclosed the claimed methods of these patents. This decision comes after a previous ruling was nullified by the Federal Circuit, demonstrating the complexity and intricacies involved in patent litigation. The judge’s…

Read More

USPTO Issues New Guidance to Streamline Patent Eligibility Declarations Under Section 101

The U.S. Patent and Trademark Office (USPTO) recently issued guidance on best practices for submitting subject matter declarations under Section 101 of the Patent Act. According to USPTO Director John Squires, patent applicants should provide these statements separately from other evidence and submit them at the earliest possible stage during the application process. These recommendations…

Read More

Baker Botts Patent Attorney Denies Settlement in Defamation Suit: A Florida Federal Court Update

In a recent development in the legal sector, a Baker Botts LLP patent attorney has refuted claims by an inventor regarding a supposed settlement deal in a defamation lawsuit. This dispute is unfolding in a Florida federal court, where the inventor alleges that an agreement was reached, while the attorney maintains otherwise. The situation highlights…

Read More

Baker Botts Patent Attorney Challenges Alleged Settlement in High-Stakes Defamation Case

A patent attorney from Baker Botts LLP is contesting an inventor’s assertion that they reached an agreement in a defamation lawsuit in Florida federal court. This legal confrontation highlights the complexities often involved in litigation where settlement terms can become contentious. The dispute arises as the inventor claims an accord was met, an assertion which…

Read More

Qualcomm Seeks to Block Supreme Court Review in FedEx Patent Dispute Ruling

Qualcomm has moved to prevent the U.S. Supreme Court from considering FedEx’s request to review a Federal Circuit decision. This decision declined to challenge Qualcomm’s adherence to real-party-in-interest requirements in a patent dispute. Qualcomm argues that the situational specifics of this case are unlikely to recur, rendering the review unnecessary. The company contends that the…

Read More

The Federal Circuit’s Overlooked Role in U.S. Supreme Court Clerkships: An Analysis of Judicial Hiring Trends

In the landscape of judicial clerkship, the role of former clerks ascending to positions at the Supreme Court is a distinguished honor that underscores both the prestige of the clerkship and the ongoing influence of its alumni. Despite this significance, the U.S. Court of Appeals for the Federal Circuit, established in 1982, has largely been…

Read More

Apple Challenges $5.7 Billion Patent Verdict: A High-Stakes Legal Battle Unfolds

Apple Inc. is gearing up to contest a substantial $5.7 billion verdict handed down for infringing on Taction Technology Inc.’s vibration technology patents. This record-setting award surpasses previous significant verdicts, many of which were subsequently overturned. Apple’s legal team has already laid out its arguments, aiming to have this verdict reversed, a strategy frequently seen…

Read More

Bayer CropScience’s Patent Lawsuit Against COVID-19 Vaccine Makers Cleared to Proceed in Delaware Court

Bayer CropScience achieved a legal victory as a judge in Delaware permitted the continuation of its patent infringement lawsuits against major COVID-19 vaccine makers Pfizer, BioNTech, and Moderna. The decision, delivered on Monday, underscores Bayer’s assertion that these companies’ COVID-19 vaccines are in violation of its patent rights. This development could have significant implications for…

Read More

USPTO Director’s Anniversary Celebration Postponed Amid Ethics Scrutiny, Reflecting Prioritization of Ethical Standards

John Squires, the Director of the U.S. Patent and Trademark Office, recently postponed a planned celebration marking his first year in office. The decision came after the event faced scrutiny over potential ethics concerns. A source familiar with the situation noted that the planned celebration was considered unprecedented for the agency, raising eyebrows among legal…

Read More

California Federal Court Imposes $1.4 Million Fee on Attorney for Misconduct in Netflix Patent Case

A recent ruling from a California federal judge has significant implications for legal accountability in patent infringement cases. Intellectual property attorney Bill Ramey has been ordered to pay nearly $1.4 million in attorney fees to Netflix due to what the court described as “bad faith” conduct. This decision shines a spotlight on the responsibility of…

Read More

Federal Judge Dismisses Cannabis Patent Lawsuit Against Trulieve, Setting Key Industry Precedent

In a notable decision for the cannabis industry, a federal judge in Florida has dismissed a patent infringement lawsuit brought against Trulieve Inc., a leading cannabis company. The complaint, filed by a competing patent company, alleged that Trulieve had infringed multiple patents related to tetrahydrocannabinol (THC) processing and products. This ruling marks a significant moment…

Read More

Federal Judge Denies Sanctions in GM-LKQ Design Patent Dispute, Shaping Legal Landscape for Automotive Industry

In a recent development in the ongoing patent litigation between General Motors (GM) and LKQ Corporation, a federal judge has denied both parties’ requests for sanctions. The case, which centers around the design of vehicle fenders, had previously led the Federal Circuit to establish more flexible standards for determining whether a design patent could be…

Read More

U.S. Government Urges Supreme Court to Uphold Patent Office’s Discretion in Inter Partes Review Denials

The U.S. government has urged the Supreme Court to decline Tesla Inc.’s petition challenging the U.S. Patent and Trademark Office’s (USPTO) discretionary authority in denying inter partes review (IPR) petitions. The government contends that the USPTO is not obligated to grant such requests, emphasizing the agency’s discretion in managing patent challenges. Tesla’s petition arises from…

Read More

Court Dismisses Patent Claims, Advances Copyright Dispute in ModoPayments vs. Volvo Financial Case

A recent ruling by the U.S. District Court for the District of Delaware has dismissed patent infringement claims brought by ModoPayments, LLC against Volvo Financial Services LLC, while allowing copyright infringement allegations to proceed. ModoPayments, a Texas-based company specializing in digital payment solutions, initiated legal action against Volvo Financial Services in July 2024. The complaint…

Read More

Delaware Supreme Court Ruling Clarifies Financial Liabilities in Veterinary Patent Case

The Delaware Supreme Court recently delivered a nuanced decision in a complex veterinary implant patent case, impacting both liability and financial obligations. The court found the founder liable for a $9.8 million licensing fee, in addition to approximately $2.4 million in defense costs. However, the court overturned a previous ruling that required the founder to…

Read More

Corteva and Inari Settle Seed Patent Dispute Early in Delaware Federal Court Trial

In a notable development in agricultural biotechnology litigation, Corteva Agriscience and Inari Agriculture Inc. have concluded a legal dispute over seed patents just three days into a trial at the Delaware federal court. The settlement resolves claims that Inari infringed on three of Corteva’s patents and misappropriated seed samples. Legal agreements were finalized swiftly after…

Read More

Burford Capital Awaits Appeal Outcome on $1.4 Billion Patent Verdict Against Apple

Burford Capital recently declared its claim to $1.4 billion from a substantial $5.7 billion jury verdict in a patent infringement case against Apple. However, the litigation funding firm remains cautious, acknowledging the potential for the verdict to be overturned or reduced upon appeal. This development underscores the unpredictable nature of patent litigation, which can yield…

Read More

Burford Capital Secures $1.4 Billion Win from Apple Patent Verdict, Highlighting Rise of Litigation Funding

Burford Capital is poised to receive a significant payout following a patent infringement verdict against tech giant Apple Inc. The finance firm expects to collect $1.4 billion based on a judgment linked to its investment in a patent dispute involving Optis Wireless Technology LLC and Apple. This case underscores the growing role litigation finance firms…

Read More

Federal Circuit Upholds Invalidation of Speech Recognition Patent in Apple Case, Highlighting Patent Scrutiny

In a significant development in the realm of intellectual property law, the Federal Circuit Court has upheld the Patent Trial and Appeal Board’s decision to fully invalidate a speech recognition patent, central to a legal dispute involving Apple Inc. The patent in question had been cited in allegations against Apple for potentially infringing upon its…

Read More

Delaware Court Clears Teva and Apotex of Infringement in Vanda’s Hetlioz Patent Case

A Delaware federal court has ruled that Teva Pharmaceuticals and Apotex Inc., key players in the generic drug industry, are not infringing upon patents held by Vanda Pharmaceuticals concerning the sleep medication Hetlioz. This decision follows Vanda’s assertion that its patent rights were breached by the production and sale of generic versions of the drug….

Read More

“Rising Requests for Continued Examination Reflect Shifts in U.S. Patent Office Operations”

The U.S. Patent and Trademark Office (USPTO) has observed a notable increase in requests for continued examination of patent applications, reflecting changes in its operational dynamics. This development is largely credited to the agency’s efforts to reduce the backlog of new applications, leading to a rapid processing environment. The swift handling of initial applications often…

Read More

PTAB Ruling Invalidates Key Patent Claims in Wearable Breast Pump Case, Highlighting Importance of Robust IP Strategies

In a recent decision by the Patent Trial and Appeal Board (PTAB), all claims challenged by Shenzhen Root Technology Co., Ltd. in the patent associated with the Willow Blossom wearable breast pump have been invalidated. The decision was reached on multiple grounds, affecting a key aspect of intellectual property within the healthcare technology sector here….

Read More